TCRX earnings: a negative outcome, -9.9%

On August 10, 2022, TScan Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -9.9% in the window around the event. It had already run +16.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.